Insmed
INSM
#1051
Rank
C$32.80 B
Marketcap
C$151.35
Share price
1.79%
Change (1 day)
10.54%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -C$1.66 Billion

According to Insmed's latest financial reports the company's current earnings are C$0.60 Billion. a decrease over its 2024 earnings that were of -C$1.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -C$1.7 Billion43.91%
2024 -C$1.18 Billion23.71%
2023 -C$0.96 Billion45.77%
2022 -C$0.66 Billion15.83%
2021 -C$0.57 Billion50.19%
2020 -C$0.38 Billion16.4%
2019 -C$0.33 Billion-23.9%
2018 -C$0.43 Billion59.35%
2017 -C$0.27 Billion8.52%
2016 -C$0.25 Billion47.25%
2015 -C$0.17 Billion34.53%
2014 -C$0.13 Billion58.83%
2013 -C$77.91 Million35.14%
2012 -C$57.65 Million-31.92%
2011 -C$84.69 Million854.92%
2010 -C$8.87 Million-105.22%
2009 C$0.16 B-905.06%
2008 -C$21.1 Million-27.31%
2007 -C$29.02 Million-62.41%
2006 -C$77.19 Million98.19%
2005 -C$38.95 Million0.03%
2004 -C$38.94 Million159.07%
2003 -C$15.03 Million-69.31%
2002 -C$48.97 Million
2000 -C$44.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.40 B-1,421.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
C$13.90 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$7.18 B-523.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-C$1 Billion-41.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-C$33 Million-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-C$2.68 Million-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA